Institute of Technology 11 Biological Sciences Research Institute Israel 10 Healthcare Insurance 10 Scientific Publisher 10 Biotech – Immunotherapy 9 Biotech – Israel 9 Government Agency – Drug Administration 8 Healthcare Insurance Company 8 HMO 8 Big Pharma – France 7 Institute of Technology – Is...
CRISPR-Cas9 is a unique technology that enables geneticists and medical researchers to edit parts of the genome by removing, adding or altering sections of DNA sequence. It is faster, cheaper and more accurate than previous techniques of editing DNA and can have a wide range of potential applica...
Small Molecules in Development of Therapeutic Drugs, Statistical Methods for Research Evaluation, Stress Disorders, Stroke, Stroke, Systemic Inflammatory Diseases as CVD Risk, Systemic Inflammatory Response Related Disorders, ...
It has been a while since I have added to this series but there have been a plethora of exciting biotech startups in the Philadelphia area, and many new startups combining technology, biotech, and machine learning. One such exciting biotech isProteovant Therapeutics, which is combining the n...
Dr. Carnevale is an Associate Professor in the Institute for Computational Molecular Science in the College of Science & Technology, Temple University. He holds multiple NIH RO1 and NSF grants. Vincenzo Carnevale received B.Sc. and M.Sc. degrees in Physics from the University of Pisa and a ...
Clinical issues – not easy way for treatment wiht a cell line and bioreactors and modalities less similar to autologoous celles CAR-T in oncology lessons now are transferred to Immune disease Cell therapy requires technologies to mature multiple modali...
IMAGE: THIS IS THE INSILICO MEDICINE LOGO.view more CREDIT: INSILICO MEDICINE Summary: Some of the most promising drugs for cancer therapy called checkpoint inhibitors often result in complete remissions, however, a majority of patients fail cancer immunotherapy with antibodies targeting immune ...
Clinical issues – not easy way for treatment wiht a cell line and bioreactors and modalities less similar to autologoous celles CAR-T in oncology lessons now are transferred to Immune disease Cell therapy requires technologies to mature multiple modalities and multiple ...
Innovation at a crossroads: Keys to unlocking the value of science and technology The industry has long discussed the promise of technology and the acceleration it provides in scientific advancement and across the industry value chain. However, the promise of its impact has yet to fully be realize...